Taiwan · Investor

China Development Industrial Bank (CDIB)

Last cheque observed Sep 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietGrowth equityWebsite unconfirmed

GrowthSeedSeries AAerospaceMachine LearningBanking

Cheques on record
0%of best year0cheques in 12 months, 30 on record
Since the last cheque4044days00hrs00min00sec
Median round$25MRounds led0 of 30Sole investor1 roundsExits13 from the portfolioMostly inUnited States, 93%
Pitch China Development Industrial Bank (CDIB)

China Development Industrial Bank (CDIB) highlights

  1. 01

    30 rounds on record

  2. 02

    Mostly Series B and Series C: 48% of its rounds

  3. 03

    Sole investor in 1 rounds, median $34M

  4. 04

    13 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Stages
GrowthSeedSeries A
Sectors
AerospaceMachine LearningBanking
Based in
Taiwan
Cold pitches
Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first30 appearances

  1. 2015

    2 rounds

  2. Sept
    KaixindaiSeed$34MSole investor
  3. Sept
    GuahaoGrowth · CN$395MWith 4 others
  4. 2013

    1 round

  5. Aug
    ApexigenSeries A · US · finsmes.com$20MWith 4 others
  6. 2005

    4 rounds

  7. Dec
    Optimer PharmaceuticalsSeries D · US$22MWith 7 others
  8. Dec
    Light Sciences OncologySeries A · US · lsoncology.com$67MWith 7 others
  9. Oct
    Light Sciences OncologySeries A · US$35MWith 3 others
  10. Jun
    PiximSeries A · US · mayfield.com$12MWith 6 others
  11. 2004

    5 rounds

  12. Dec
    CipherMaxVenture · US$29MWith 5 others
  13. Jun
    Continuous ComputingVenture · US$15MWith 6 others
  14. Mar
    TaigenSeries B · TW · taigenbiotech.com.tw$38MWith 7 others
  15. Feb
    MorphotekSeries C · US$26MWith 9 others
  16. Jan
    TargeGenSeries B · US$30MWith 4 others
  17. 2003

    8 rounds

  18. Dec
    Xanthus PharmaceuticalsSeries B · US$31MWith 10 others
  19. Nov
    ZeevoSeries E · US$20MWith 5 others
  20. Aug
    CaviumSeries C · US$18MWith 5 others
  21. Jul
    ZettaComSeries C · US$19MWith 13 others
  22. May
    SantarusSeries D · US$51MWith 9 others
  23. May
    Sandbridge TechnologiesSeries B · US$20MWith 5 others
  24. Apr
    NanosysSeries B · US$30MWith 12 others
  25. Apr
    PiximSeries D · US$22MWith 4 others
  26. 2002

    5 rounds

  27. Oct
    HeyAnitaSeries D · US$7.0MWith 2 others
  28. Sept
    CipherMaxSeries B · US$25MWith 13 others
  29. Mar
    SiRF TechnologySeries H · US$20MWith 9 others
  30. Jan
    MedinoxVenture · US$14MWith 8 others
  31. Jan
    MyogenSeries D · US$14MWith 3 others
  32. 2001

    5 rounds

  33. Sept
    PTC TherapeuticsVenture · US$40MWith 9 others
  34. Aug
    HeyAnitaSeries C · USUndisclosedWith 3 others
  35. Mar
    CalimetricsSeries C · US$25MWith 7 others
  36. Mar
    VaultusSeries B · US$32MWith 5 others
  37. Jan
    WintegraSeries B · US · liquidscenarios.com$21MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed13 in all

SantarusBought by Salix Pharmaceuticals$2.6BNov 2013
PTC TherapeuticsListed$125MJun 2013
PiximBought by SonyUndisclosedSept 2012
Continuous ComputingBought by RadisysUndisclosedMay 2011
WintegraBought by PMC-Sierra$300MNov 2010
TargeGenBought by Sanofi Aventis$635MJun 2010
Xanthus PharmaceuticalsBought by AntisomaUndisclosedMay 2008
HeyAnitaBought by KirusaUndisclosedJan 2007
MyogenBought by Gilead SciencesUndisclosedOct 2006
ZeevoBought by BroadcomUndisclosedMar 2005
SantarusListedUndisclosedApr 2004
ZettaComBought by IDT$35MApr 2004

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as China Development Industrial Bank (CDIB). A count of rooms they were both in, not a relationship either has claimed.

Quick answers about China Development Industrial Bank (CDIB)

What does China Development Industrial Bank (CDIB) invest in?

China Development Industrial Bank (CDIB) invests most often at Series B and Series C (48% of the rounds on record), in sectors such as Aerospace, Machine Learning and Banking.

How active is China Development Industrial Bank (CDIB)?

30 investments on record, 0 of them in the last 12 months. The most recent was in Sept 2015.

How big are China Development Industrial Bank (CDIB)'s cheques?

The median round it joins is $25M.

Does China Development Industrial Bank (CDIB) lead rounds?

Rarely, if at all: none of its 30 investments on record names it as the lead.

Where does China Development Industrial Bank (CDIB) invest?

Most of the companies it backs are in the United States (93%).

Is China Development Industrial Bank (CDIB) investing now?

No investments in the last 12 months; the latest was in Sept 2015.

Who does China Development Industrial Bank (CDIB) invest alongside?

Most often Intel Capital (4 rounds together), Venrock (4 rounds together) and Chiao Tung Bank (3 rounds together).

What kind of investor is China Development Industrial Bank (CDIB)?

China Development Industrial Bank (CDIB) is a growth equity firm based in Taiwan.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it